We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.63B
AUM Growth
+$94.2M
Cap. Flow
+$27.6M
Cap. Flow %
0.76%
Top 10 Hldgs %
13.59%
Holding
1,401
New
111
Increased
550
Reduced
536
Closed
104

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$7.95M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$5.7M
3
BABA icon
Alibaba
BABA
+$4.81M
4
STX icon
Seagate
STX
+$4.36M
5
GEN icon
Gen Digital
GEN
+$4.27M

Top Sells

Rank Stock Value
1
UAL icon
United Airlines
UAL
+$8.72M
2
BP icon
BP
BP
+$5.06M
3
BAC icon
Bank of America
BAC
+$4.8M
4
EXPE icon
Expedia Group
EXPE
+$4.54M
5
UPS icon
United Parcel Service
UPS
+$4.17M

Sector Composition

Rank Sector Weight
1 Healthcare 13.46%
2 Financials 11.9%
3 Technology 10.61%
4 Industrials 9.36%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$127B
$20M 0.55%
358,509
+8,813
+3% +$480K
HON icon
27
Honeywell
HON
$77B
$19.9M 0.55%
165,625
+20,720
+14% +$2.44M
GOOG icon
28
Alphabet (Google) Class C
GOOG
$3.91T
$19.9M 0.55%
438,500
+28,200
+7% +$1.29M
V icon
29
Visa
V
$675B
$19.9M 0.55%
211,880
+9,098
+4% +$844K
T icon
30
AT&T
T
$164B
$19.7M 0.54%
691,466
+2,409
+0.3% +$71K
VZ icon
31
Verizon
VZ
$193B
$19.2M 0.53%
429,385
-4,690
-1% -$218K
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$18.4M 0.51%
76,290
-5,141
-6% -$1.23M
MRK icon
33
Merck
MRK
$324B
$18.3M 0.51%
299,883
-8,652
-3% -$527K
WLY icon
34
John Wiley & Sons Class A
WLY
$2.51B
$17.9M 0.49%
339,070
APU
35
DELISTED
AmeriGas Partners, L.P.
APU
$17.8M 0.49%
394,355
-16,716
-4% -$750K
PEP icon
36
PepsiCo
PEP
$187B
$17.8M 0.49%
153,918
-3,542
-2% -$406K
MO icon
37
Altria Group
MO
$122B
$17.6M 0.48%
236,063
-20,160
-8% -$1.47M
CELG
38
DELISTED
Celgene Corp
CELG
$17.1M 0.47%
131,391
+12,194
+10% +$1.49M
LUV icon
39
Southwest Airlines
LUV
$22.1B
$16.9M 0.47%
272,218
-14,817
-5% -$862K
ABBV icon
40
AbbVie
ABBV
$457B
$16.6M 0.46%
229,339
+5,702
+3% +$383K
CSCO icon
41
Cisco
CSCO
$450B
$16.4M 0.45%
524,735
-14,868
-3% -$484K
MET icon
42
MetLife
MET
$60.8B
$16.3M 0.45%
332,587
-9,220
-3% -$428K
DIS icon
43
Walt Disney
DIS
$165B
$15.5M 0.43%
146,043
+4,512
+3% +$494K
ILMN icon
44
Illumina
ILMN
$29.4B
$15.2M 0.42%
89,832
-19,320
-18% -$3.34M
PG icon
45
Procter & Gamble
PG
$343B
$15.1M 0.42%
173,034
-8,029
-4% -$708K
EFA icon
46
iShares MSCI EAFE ETF
EFA
$76.4B
$15M 0.41%
230,596
+64,984
+39% +$4.2M
PM icon
47
Philip Morris
PM
$300B
$15M 0.41%
127,566
+668
+0.5% +$77.4K
BIIB icon
48
Biogen
BIIB
$29.9B
$15M 0.41%
55,118
-837
-1% -$221K
CVX icon
49
Chevron
CVX
$386B
$14.8M 0.41%
142,160
+2,466
+2% +$261K
TMO icon
50
Thermo Fisher Scientific
TMO
$212B
$14.7M 0.41%
84,483
+9,290
+12% +$1.56M

Similar funds

Oppenheimer & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Oppenheimer & Co held 1,401 positions worth $3.63B, up 2.7% from $3.53B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q2 2017 filing shows 111 new, 550 increased, 536 reduced and 104 closed positions. Its largest new stake was Seagate: 99,859 shares worth $3.87M. The largest sale was United Airlines, an estimated $8.72M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q2 2017 buy was Seagate: 99,859 shares worth $3.87M.
  • Oppenheimer & Co added most to Goldman Sachs in Q2 2017, an estimated $7.95M increase.
  • Oppenheimer & Co's biggest Q2 2017 reduction was United Airlines, cutting an estimated $8.72M.
  • Oppenheimer & Co fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $2.13M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.63B portfolio in Q2 2017.
  • Oppenheimer & Co opened 111 new positions and closed 104 in Q2 2017.
  • Oppenheimer & Co's portfolio value rose 2.7% quarter-over-quarter to $3.63B.

Based on Oppenheimer & Co's 13F filing for Q2 2017, filed 9 Aug 2017.